Impact of multiple malignancies on surgical outcomes in patients with 1 cm or smaller non-small cell lung cancer

被引:1
|
作者
Tsukioka, Takuma [1 ]
Izumi, Nobuhiro [1 ]
Mizuguchi, Shinjiro [1 ]
Kyukwang, Chung [1 ]
Komatsu, Hiroaki [1 ]
Toda, Michihito [1 ]
Hara, Kantaro [1 ]
Miyamoto, Hikaru [1 ]
Nishiyama, Noritoshi [1 ]
机构
[1] Osaka City Univ Hosp, Dept Thorac Surg, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan
关键词
Non-small cell lung cancer; Multiple malignancies; Treatment interval; Prognostic factor; RECURRENCE; CARCINOMA; SURVIVAL; LESS;
D O I
10.1007/s10147-017-1185-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Because most patients with small-sized non-small cell lung cancer (NSCLC) are asymptomatic, their lesions are detected by cancer screenings or routine checkups for other diseases. Incidences of multiple malignancies have been reported to be 27% in patients with stage I-III NSCLC. Some patients have treatment histories for other malignancies, and their small-sized NSCLC was incidentally detected during follow-up. There is no established report regarding the influence of multiple malignancies on small-sized NSCLC prognosis. Therefore, we investigated the correlation between multiple malignancies and surgical outcomes in patients with small-sized NSCLC. In total, 44 patients underwent definitive pulmonary resection for NSCLC of 1 cm or smaller between January 2003 and December 2012. Tumor size was measured by macroscopic findings of the resected specimens, and we then retrospectively investigated their clinical courses. One patient had hemoptysis symptoms, whereas 43 patients were asymptomatic; among them, NSCLC was detected by examinations for other diseases in 31 patients and by cancer screening in 12 patients. In total, 20 patients (45%) had multiple malignancies. The median follow-up period was 68 months. One patient had a recurrence from current NSCLC. No patients died of current NSCLC. The overall 5-year survival rate was 90% for all patients. Patients with multiple malignancies had significantly poorer prognoses compared with those without multiple malignancies (P = 0.016). However, patients with treatment intervals of more than 5 years had prognoses equivalent to those of patients without multiple malignancies (P = 0.829). Only the presence of multiple malignancies was a significantly poor prognostic factor in univariate and multivariate analyses. NSCLC of 1 cm or smaller showed good prognoses. The presence of multiple malignancies was a significantly poor prognostic factor, and short treatment intervals also correlated with poor prognosis.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 50 条
  • [21] Surgical treatment in non-small cell lung cancer with pulmonary oligometastasis
    He, Jinyuan
    Li, Yun
    An, Jun
    Hu, Liu
    Zhang, Junhang
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [22] Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer
    Schuchert, Matthew J.
    Kilic, Arman
    Pennathur, Arjun
    Nason, Katie S.
    Wilson, David O.
    Luketich, James D.
    Landreneau, Rodney J.
    ANNALS OF THORACIC SURGERY, 2011, 91 (06) : 1681 - 1688
  • [23] Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers
    Zhang, Zhirong
    Gao, Shugeng
    Mao, Yousheng
    Mu, Juwei
    Xue, Qi
    Feng, Xiaoli
    He, Jie
    SCIENTIFIC REPORTS, 2016, 6
  • [24] Impact of Tyrosine Kinase Inhibitor Starting Dose on Outcomes in Patients With Non-Small Cell Lung Cancer
    Miao, Emily
    Seetharamu, Nagashree
    Sullivan, Kevin
    Eng, Stephen
    Lee, Chung-Shien
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (01) : 11 - 16
  • [25] Impact of Race on Outcomes of Advanced Stage Non-Small Cell Lung Cancer Patients Receiving Immunotherapy
    Pasli, Melisa
    Kannaiyan, Radhamani
    Namireddy, Praveen
    Walker, Paul
    Muzaffar, Mahvish
    CURRENT ONCOLOGY, 2023, 30 (04) : 4208 - 4221
  • [26] Impact of Interstitial Lung Disease on Survival for Patients with Non-small Cell Lung Cancer
    Miyazaki, Kunihiko
    Satoh, Hiroaki
    Kurishima, Koichi
    Nakamura, Ryota
    Ishikawa, Hiroichi
    Kagohashi, Katsunori
    Ohara, Gen
    Hizawa, Nobuyuki
    ANTICANCER RESEARCH, 2009, 29 (07) : 2671 - 2674
  • [27] Prognosis associated with synchronous or metachronous multiple primary malignancies in patients with completely resected non-small cell lung cancer
    Komatsu, Hiroaki
    Izumi, Nobuhiro
    Tsukioka, Takuma
    Inoue, Hidetoshi
    Hara, Kantaro
    Miyamoto, Hikaru
    Nishiyama, Noritoshi
    SURGERY TODAY, 2019, 49 (04) : 343 - 349
  • [28] Surgical Management of Oligometastatic Non-Small Cell Lung Cancer
    Lanuti, Michael
    THORACIC SURGERY CLINICS, 2016, 26 (03) : 287 - +
  • [29] Iterative surgical resections in non-small cell lung cancer
    Ucvet, Ahmet
    Yazgan, Serkan
    Samancilar, Ozgur
    Gursoy, Soner
    Erbaycu, Ahmet Emin
    Komurcuoglu, Berna
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA-POLISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 18 (04) : 221 - 226
  • [30] Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller
    Tao, Hiroyuki
    Hayashi, Tatsuro
    Sano, Fumiho
    Takahagi, Akihiro
    Tanaka, Toshiki
    Matsuda, Eisuke
    Okabe, Kazunori
    JOURNAL OF SURGICAL RESEARCH, 2013, 185 (01) : 250 - 254